Lamotrigine and Ataxia aggravated - a phase IV clinical study of FDA data
Ataxia aggravated is found among people who take Lamotrigine, especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Lamotrigine and have Ataxia aggravated. It is created by eHealthMe based on reports of 55,156 people who have side effects when taking Lamotrigine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
55,156 people reported to have side effects when taking Lamotrigine.
Among them, 647 people (1.17%) have Ataxia aggravated.
What is Lamotrigine?
Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 58,334 Lamotrigine users for its effectiveness, alternative drugs and more.
What is Ataxia aggravated?
Ataxia aggravated (serious loss of full control of bodily movements) is found to be associated with 714 drugs and 297 conditions by eHealthMe.
Number of Lamotrigine and Ataxia aggravated reports submitted per year:
Time on Lamotrigine when people have Ataxia aggravated *:
Gender of people who have Ataxia aggravated when taking Lamotrigine*:
Age of people who have Ataxia aggravated when taking Lamotrigine *:
Common drugs people take besides Lamotrigine *:
Common side effects people have besides Ataxia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lamotrigine and have Ataxia aggravated?Check whether Ataxia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
Alternative drugs to, pros and cons of Lamotrigine:
- Lamotrigine (58,334 reports)
Ataxia aggravated treatments and more:
- Ataxia aggravated (6 reports)
COVID vaccines that are related to Ataxia aggravated:
- Ataxia aggravated in Moderna COVID Vaccine
- Ataxia aggravated in Pfizer BioNTech Covid Vaccine
- Ataxia aggravated in Johnson and Johnson Covid Vaccine
How severe was Ataxia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of lamotrigine:
Common drugs associated with Ataxia aggravated:
All the drugs that are associated with Ataxia aggravated:
- Ataxia aggravated (714 drugs)
Common conditions associated with Ataxia aggravated:
All the conditions that are associated with Ataxia aggravated:
- Ataxia aggravated (297 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamotrigine) and Lamotrigine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Asacol and Triamcinolone Acetate drug interaction - 6 seconds ago
- Refractory Anaemia With An Excess Of Blasts and Cardiac Failure Aggravated - 12 seconds ago
- Prednisone vs. Lunesta - 18 seconds ago
- Benicar and Energy Increased - 19 seconds ago
- Trulicity and Orthostatic Hypotension - 26 seconds ago